Table 1.
Patient characteristics.
| Patient Characteristics and Events | |||
|---|---|---|---|
| Age at baseline imaging | Follow-up after treatment | ||
| Median (IQR *) | 63 (56.5–67) | Follow-up in months (IQR *) | 30.7 (17.8–38.7) |
| Sex | Treatment | ||
| Female | 16 | Chemoradiotherapy | 53 |
| Male | 42 | Cisplatin | 49 |
| Tobacco use | Cetuximab | 4 | |
| None (%) | 21 (36.8) | Radiotherapy only | 4 |
| Smoker (%) | 36 (63.2) | No. tumor-related events | |
| HPV positive (%) | 20 (44.4) † | Locoregional recurrence | 18 |
| Primary tumor location | Distant metastases | 20 | |
| Oropharynx | 45 | Tumor-related death | 17 |
| Hypopharynx | 12 | ||
| T stage (n = 58) | |||
| 2 | 18 | ||
| 3 | 15 | ||
| 4 | 25 | ||
| N stage (n = 58) | |||
| 0 | 13 | ||
| 1 | 8 | ||
| 2 | 34 | ||
| 3 | 2 | ||
* Interquartile range; † measured in the oropharynx.